Everything tagged "dividend" across the TickerSpark archives.
Church & Dwight pairs durable branded-consumer growth with strong cash generation, but the stock’s premium valuation keeps the call at Hold. Q1 showed solid organic growth and margin expansion, yet upside looks limited near the current fair value.
Banco Santander Brasil offers a Buy case built on balance-sheet discipline, a large client base, and a cheaper forward valuation as management resets credit quality. Near-term growth is muted, but the bank’s mix shift toward secured lending and higher-quality customers could support earnings recovery.
WisdomTree posted record Q1 2026 AUM and broad-based inflows, but leverage and acquisition execution keep the stock in Hold territory. Rising revenue and EPS estimates support the growth case, while valuation and balance sheet risk cap upside.
Clorox remains a durable branded-staples name, but flat revenue, higher debt, and a difficult ERP transition keep the stock in Hold territory. Household and International are improving, yet Fresh Step and Food remain key execution challenges.
Atmus Filtration Technologies combines a recurring aftermarket base, improving margins, and a broadened filtration platform after the Cook Filter acquisition. The stock looks reasonably valued versus its growth outlook, supporting a moderate-risk Buy.
GSK is leaning on specialty medicines, Shingrix, and a strong HIV franchise to offset declines in legacy categories. The stock looks fairly valued with modest upside, making it more of a steady Hold than a high-conviction buy.
Ingersoll Rand combines a durable industrial portfolio, 36.5% aftermarket revenue, and improving growth, but valuation and leverage keep the stock at Hold. Q1 2026 showed solid order momentum, yet the shares already price in much of the recovery.
KKR combines a massive fee-paying asset base, strong fundraising, and a growing insurance platform with recurring earnings momentum. Leverage and monetization timing keep the stock in moderate-risk territory, but the long-term setup remains constructive.
Altria combines strong cash generation and Marlboro pricing power with a growing on! pouch franchise, but cigarette volume declines and leverage keep the stock in Hold territory.
Starbucks is showing real turnaround progress with stronger comps, rising Rewards engagement, and a China restructuring that could improve margins. But the stock still screens expensive, so the case remains a Hold.
Valero posted a sharp Q1 2026 rebound in refining income and continues to generate strong free cash flow, but the stock still screens as fairly valued near the current price. The report keeps VLO at Hold as cyclicality and valuation offset the operating recovery.
Parker-Hannifin posted record Q3 sales, strong aerospace momentum, and raised guidance, but the stock’s premium valuation keeps the rating at Hold. The business quality is high, yet leverage and a 29.0x forward P/E limit upside from here.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime